Increased plasma XOR activity induced by NAFLD/NASH and its possible involvement in vascular neointimal proliferation
Xanthine oxidoreductase (XOR) is an enzyme that catalyzes hypoxanthine to xanthine and xanthine to uric acid, respectively. However, the underlying mechanisms of increased plasma XOR and its pathological roles in systemic diseases, such as atherosclerosis, are not fully understood. In this study, we...
Main Authors: | Yusuke Kawachi, Yuya Fujishima, Hitoshi Nishizawa, Takashi Nakamura, Seigo Akari, Takayo Murase, Takuro Saito, Yasuhiro Miyazaki, Hirofumi Nagao, Shiro Fukuda, Shunbun Kita, Naoto Katakami, Yuichiro Doki, Norikazu Maeda, Iichiro Shimomura |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical investigation
2021-09-01
|
Series: | JCI Insight |
Subjects: | |
Online Access: | https://doi.org/10.1172/jci.insight.144762 |
Similar Items
-
Plasma xanthine oxidoreductase activity in Japanese patients with type 2 diabetes across hospitalized treatment
by: Yusuke Kawachi, et al.
Published: (2021-08-01) -
Multicytokine-producing CD4+ T cells characterize the livers of patients with NASH
by: Anna Woestemeier, et al.
Published: (2023-01-01) -
Altered branched-chain α-keto acid metabolism is a feature of NAFLD in individuals with severe obesity
by: Thomas Grenier-Larouche, et al.
Published: (2022-08-01) -
Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD
by: Lindsay T. Fourman, et al.
Published: (2020-08-01) -
SEMA7AR148W mutation promotes lipid accumulation and NAFLD progression via increased localization on the hepatocyte surface
by: Nan Zhao, et al.
Published: (2022-08-01)